FAMOTIDINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Famotidine, and what generic alternatives are available?
Famotidine is a drug marketed by Ajanta Pharma Ltd, Akorn, Alkem Labs Ltd, Amneals Pharms, Annora Pharma, Carnegie, Lupin Ltd, Micro Labs, Navinta Llc, Novel Labs Inc, Novitium Pharma, Unichem, Upsher Smith Labs, Apotex Inc, Apothecon, Fresenius Kabi Usa, Hikma, Hospira, Mylan Labs Ltd, Sagent, Zydus Pharms, Perrigo, Actavis Elizabeth, Alembic Pharms Ltd, Apotex, Ascent Pharms Inc, Aurobindo Pharma, Aurobindo Pharma Ltd, Carlsbad, Chartwell Rx, Contract Pharmacal, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Graviti Pharms, Ivax Sub Teva Pharms, Mankind Pharma, Marksans Pharma, MSN, Mylan Pharms Inc, Natco Pharma, P And L, Perrigo R And D, Rising, Sandoz, Sun Pharm Inds Ltd, Sun Pharm Industries, Teva, Vkt Pharma, Watson Labs, Torrent, Epic Pharma Llc, Abbvie, Baxter Hlthcare, and Endo Operations. and is included in eighty-six NDAs.
The generic ingredient in FAMOTIDINE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FAMOTIDINE?
- What are the global sales for FAMOTIDINE?
- What is Average Wholesale Price for FAMOTIDINE?
Summary for FAMOTIDINE
| US Patents: | 0 |
| Applicants: | 54 |
| NDAs: | 86 |
| Finished Product Suppliers / Packagers: | 138 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Clinical Trials: | 118 |
| Patent Applications: | 5,977 |
| Drug Prices: | Drug price information for FAMOTIDINE |
| Drug Sales Revenues: | Drug sales revenues for FAMOTIDINE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FAMOTIDINE |
| What excipients (inactive ingredients) are in FAMOTIDINE? | FAMOTIDINE excipients list |
| DailyMed Link: | FAMOTIDINE at DailyMed |
See drug prices for FAMOTIDINE
Recent Clinical Trials for FAMOTIDINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Miami | Phase 3 |
| Celgene | Phase 1 |
| CURE Drug Repurposing Collaboratory (CDRC) | Phase 3 |
Pharmacology for FAMOTIDINE
| Drug Class | Histamine-2 Receptor Antagonist |
| Mechanism of Action | Histamine H2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for FAMOTIDINE
Anatomical Therapeutic Chemical (ATC) Classes for FAMOTIDINE
US Patents and Regulatory Information for FAMOTIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn | FAMOTIDINE | famotidine | TABLET;ORAL | 217400-001 | Aug 6, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | FAMOTIDINE | famotidine | TABLET;ORAL | 075062-002 | Apr 16, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apotex | FAMOTIDINE | famotidine | TABLET;ORAL | 075611-002 | Jul 23, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | FAMOTIDINE | famotidine | TABLET;ORAL | 217375-001 | Apr 24, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
